NovaBay Pharmaceuticals, Inc. — Form D

NovaBay Pharmaceuticals, Inc. of EMERYVILLE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-18. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (58)

Showing 25 of 58 people.

NameRoleLocation
AUDREY KUNINDirectorKANSAS CITY, MO
AUDREY KUNINExecutive OfficerKANSAS CITY, MO
JEFFREY KUNINExecutive OfficerKANSAS CITY, MO
Gail MaderisDirectorRedwood City, CA
MIJIA (BOB) WUDirectorEMERYVILLE, CA
SWAN SITDirectorEMERYVILLE, CA
PAUL FREIMANDirectorEMERYVILLE, CA
JULIE GARLIKOVDirectorEMERYVILLE, CA
JUSTIN HALLDirectorEMERYVILLE, CA
JUSTIN HALLExecutive OfficerEMERYVILLE, CA
TOMMY LAWExecutive OfficerEMERYVILLE, CA
YENYOU (JEFF) ZHENGDirectorEMERYVILLE, CA
YONGXIANG (SEAN) ZHENGDirectorEMERYVILLE, CA
Andrew JonesExecutive OfficerRiverside, MO
Mark SieczkarekDirectorEl Segundo, CA
Gail E MaderisDirectorBerkeley, CA
YENYOU (JEFF) E ZHENGDirectorEMERYVILLE, CA
PAUL E FREIMANDirectorEMERYVILLE, CA
AUDREY M KUNINExecutive OfficerKANSAS CITY, MO
SWAN E SITDirectorEMERYVILLE, CA
XINZHOU (PAUL) E LIDirectorEMERYVILLE, CA
JEFFREY M KUNINExecutive OfficerKANSAS CITY, MO
MIJIA (BOB) E WUDirectorEMERYVILLE, CA
JUSTIN M HALLDirectorEMERYVILLE, CA
JUSTIN M HALLExecutive OfficerEMERYVILLE, CA

Other filings by this issuer (18)

Showing 15 of 18 filings.

FiledFormOfferingSold
2026-01-27D$134.0M$134.0M
2024-06-28D$226K$226K
2024-04-05D$665K$665K
2024-01-04D$555K$555K
2022-09-23D$3.3M$3.3M
2022-09-23D$2.1M$2.1M
2021-11-17D$15.0M$15.0M
2020-07-31D$6.8M
2020-05-22D$1.7M$1K
2020-05-01D
2019-08-26D$4.2M$4.2M
2019-08-26D$2.7M$2.7M
2019-07-03D$2.4M$2.4M
2018-02-14D$6.0M$6.0M
2016-05-20D$11.8M$7.8M

More